Reck negatively regulates matrix metalloproteinase-9 transcription

Cancer Research

Volumn 69, Issue 4, 2009, Pages 1502-1508

  Takagi, Satoshi ^a,b   Simizu, Siro ^a   Osada, Hiroyuki ^a,b  

^a RIKEN   (Japan)

^b SAITAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GLYCOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C JUN; PROTEIN RECK; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF;

CELL LINE; CELL LINE, TUMOR; CLONING, MOLECULAR; FIBROSARCOMA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; HUMANS; LUNG; MATRIX METALLOPROTEINASE 9; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, NEOPLASM; TETRADECANOYLPHORBOL ACETATE; TRANSFECTION;

EID: 60649086817     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2635     Document Type: Article

References (40)

1. Bergers G, Brekken R, McMahon G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-44.
2. Jodele S, Chantrain CF, Blavier L, et al. The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 2005;65:3200-8.
3. Bernhard EJ, Gruber SB, Muschel RJ. Direct evidence linking expression of matrix metalloproteinase 9 (92 kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc Natl Acad Sci U S A 1994;91:4293-7.
4. Sato H, Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 1993;8: 395-405.
5. Iyer V, Pumiqlia K, DiPersio CM. α3fβt1integrin regulates MMP-9 mRNA stability in immortalized keratinocytes: a novel mechanism of integrin-mediated MMP gene expression. J Cell Sci 2005;118:1185-95.
6. Ramos DN, Hahn DE, Sipley J, et al. Activation of matrix metalloproteinase-9 (MMP-9) vis a converging Plasmin/Stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999;274:13066-76.
7. Watanabe H, Nakanishi I, Yamashita K, Hayakawa T, Okada Y. Matrix metalloproteinase-9 (92 kDa gelati- nase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J Cell Sci 1993;104: 991-9.
8. Lyons JG, Birkedal HB, Pierson MC, Whitelock JM, Birkedal HH. Interleukin-1 β and transforming growth factor-α/epidermal growth factor induce expression of M(r) 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes. J Biol Chem 1993;268:19143-51.
9. Ma Z, Shah RC, Chang MJ, Benveniste EN. Coodination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol Cell Biol 2004;24:5496-509.
10. Kobayashi T, Kishimoto J, Ge Y, et al. A novel mechanism of matrix metalloproteinase-9 gene expression implies a role for keratinization. EMBO Rep 2001;2: 604-8.
11. Schwartz B, Melnikova VO, Tellez C, etal. Loss ofAP-2α in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene 2007;26:4049-58.
12. Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci U S A 1998;95:13221-6.
13. Sasahara RM, Takahashi C, Noda M. Involvement of the Sp1 site in ras-mediated down-regul ation of the RECK metastasis suppressor gene. Biochem Biophys Res Commun 1999;264:668-75.
14. Chang HC, Liu LT, Hung WC. Involvement of histone deacetylation in ras-induced down regulation of metastasis suppressor RECK. Cell Signal 2004;16:675-9.
15. Liu LT, Peng JP, Chang HC, Hung WC. RECK is a target of Epstein-Bar virus latent membrane protein 1. Oncogene 2003;22:8263-70.
16. Hsu MC, Chang HC, Hung WC. HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factor to promote cell invasion. J Biol Chem 2006;281:4718-25.
17. Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001;107:789-800.
18. Simizu S, Takagi S, Tamura Y, Osada H. RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines. Cancer Res 2005;65:7455-61.
19. Chang CK, Hung WC, Chang HC. The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. J Cell Mol Med 2008; ahead of print.
20. Furumoto K, Arii S, Mori A, et al. RECK gene expression in hepatocellular carcinoma, Correlation with invasion-related clinicopathological factors and its clinical significance. Hepatology 2001;33:189-95.
21. Takeuchi T, Hisanaga M, Nagao M, et al. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an information prognostic indicator for colorectal cancer. Clin Cancer Res 2004;10:5572-9.
22. Teruya T, Simizu S, Kanoh N, Osada H. Phoslac-tomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells. FEBS Lett 2005;579: 2463-8.
23. Tamura Y, Simizu S, Osada H. The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria. FEBS Lett 2004;569:249-55.
24. Ogawa K, Chem F, Kuang C, Chem Y. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-β is mediated by nuclear factor-κB site. Biochem J 2004;381:413-22.
25. Gum R, Lengyel E, Juarez J, et al. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA/ets and AP-1 sequences. J Biol Chem 1996;271:10672-80.
26. Simizu S, Suzuki T, Muroi M, et al. Involvement of disulfide bond formation in the activation of hepar-anase. Cancer Res 2007;67:7841-9.
27. Dubois T, Paleotti O, Mironov AA, et al. Golgilocalized GAP for Cdc42 functions downstream of ARF1 to control Arp2/3 complex and F-actin dynamics. Nat Cell Biol 2005;7:353-63.
28. Vial E, Marshall CJ. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J Cell Sci 2003;116:4957-63.
29. Holmström TH, Mialon A, Kallio M, et al. c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21. J Biol Chem 2008; 283:7046-53.
30. Koike Y, Mita K, Suzuki MG, et al. Genomic sequence of a 320-kb segment of the Z chromosome of Bombyx mori containing a kettin ortholog. Mol Gen Genomics 2003;269:137-49.
31. Wang SC, Lien HC, Xia W, et al. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 2004;6: 251-61.
32. Ma Z, Shah RC, Chang MJ, Benveniste EN. Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol Cell Biol 2004;24:5496-509.
33. Chang CK, Hung WC, Chang HC. The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. J Cell Mol Med. In press.
34. Yokoo T, Kitamura M. Dual regulation of IL-1 β-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-κB and AP-1. Am J Physiol 1996; 270:123-30.
35. Belguise K, Kersual N, Galtier F, Chalbos D. Fra-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 2005;24:1434-44.
36. Song Y, Qian L, Song S, et al. Fra-1 and Stat3 synergistically regulate activation of human MMP-9 gene. Mol Immunol 2008;45:137-43.
37. MechtaF,LallemandD,PfarrCM,YanivM. Transformation by ras modifies AP1 composition and activity. Oncogene 1997;14:837-47.
38. Casalino L, De Cesare D, Verde P. Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol Cell Biol 2003;23: 4401-15.
39. Vallone D, Battista S, Pierantoni GM, et al. Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene product. EMBO J 1997;16:5310-21.
40. Casalino L, Bakiri L, Talotta F, et al. Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription. EMBO J 2007;26: 1878-90.